There’s an opportunity to widen the therapeutic window of T-cell engagers by reducing cytokine release. See data on our CD3 x PSMA program at Festival of Biologics on April 15 - 17 to learn more. #FOBUSA

AbCellera presents data on T-cell engagers against four tumor targets at AACR 2024 ow.ly/S4Yj50RaG3F

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 ow.ly/iSB450R7TRX

See the latest data on T-cell engager programs for multiple tumor targets, including PSMA and challenging peptide-MHCs, at #AACR2024 .

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 ow.ly/XXJT50QX7CP

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions ow.ly/xunz50QQ7fZ

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 ow.ly/wbxm50QM4fm

AbCellera Announces Resignation of Board Member investors.abcellera.com/news/news-rele…

AbCellera to Present at Upcoming Investor Conferences in March ow.ly/jYeM50QGYNV

AbCellera Reports Full Year 2023 Business Results ow.ly/H68850QFUPR

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024 ow.ly/p9CQ50QtM5f

AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024 ow.ly/iBFV50QkPpm

Learn how to build optimal #bispecifics using innovative technologies. Join Patrick Farber at his talk at the upcoming AET conference in San Diego.
Antibody Engineering #antibodyengineering

AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023
ow.ly/VJ3a50Q8x20

Learn how integrated technologies can efficiently generate antibodies that meet the TCP. Join Lucas Kraft at PEGS Europe.

AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023
ow.ly/wInv50Q412j

AbCellera Reports Q3 2023 Business Results
ow.ly/ZCt550Q3Hey

Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
ow.ly/J0Gi50Q3ecx

AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023
ow.ly/IVbV50Q2Oi3

AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023
ow.ly/FB5650PVMHp